![Frontiers | Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling | Pharmacology Frontiers | Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling | Pharmacology](https://www.frontiersin.org/files/Articles/419827/fphar-09-01336-HTML/image_m/fphar-09-01336-g001.jpg)
Frontiers | Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling | Pharmacology
![Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients - International Journal of Cardiology Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2082729134/2072915434/gr1.jpg)
Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients - International Journal of Cardiology
![Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action - Journal of the American Academy of Dermatology Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f85ce5c6-a61c-436e-9b76-746ea155e3a6/gr1_lrg.jpg)
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action - Journal of the American Academy of Dermatology
![Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717368183-fx1.jpg)
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect
![Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? | CFR Journal Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? | CFR Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/figure1-Mechanism-of-Action-of-Ivabradine.png)
Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? | CFR Journal
![Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate - The American Journal of Medicine Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aa507fdc-3153-4b68-ad39-85edc2d937f4/gr1.jpg)